VIANEX produces, imports, packages, markets and distributes a large number of well-known pharmaceuticals covering all the various therapeutic classes.

Today, there are more that 200 of these products (in all pharmacotechnical formulations) and this is a testament to the breadth of cooperation between VIANEX and major international pharmaceutical companies, and, even more than this, it shows the confidence and trust which they place in VIANEX.

The efficacy and safety of the products are verified through clinical trials, which are conducted by independent researchers in major hospitals in the country, in collaboration with the medical departments of VIANEX.
All clinical trials are planned and implemented in accordance with international standards of Good Clinical Practice (GCP - Good Clinical Practice).

VIANEX recently began to cooperate with universities on the research and development of new active molecules which are effective in the treatment of serious diseases.

VIANEX products cover the following therapeutic classes:

PRESCRIPTION (RX)

Gastrointestinal products
Antihypertensive products
Hypolipidemic products
Dermatological products
Antiosteoporotic products
Antibiotics
Vaccines
Blood derivatives
Oncology products
Anti-inflammatories
Neurology/Psychiatry
Urological products
Anti-asthmatic products
Ophthalmological products
Biotechnological products

Vianex’s portfolio also includes products to be used exclusively by hospitals.

NON-PRESCRIPTION (OTC)

Analgesics
Antiseptics

NUTRITIONAL SUPPLEMENTS

INFANT NUTRITION

DIAGNOSTICS

COSMETICS

Skin care products